Developing 1,2,3,4-Tetrahydro-5H-Aryl[1,4]Diazepin-5-Ones And Related Scaffolds As Poly-(Adp-Ribosyl) Polymerase (Parp) Inhibitors And Exploring Their Targeted Polypharmacology With Kinases